1 Organ Transplant Immunosuppressant Drugs Market Overview 1.1 Product Overview and Scope of Organ Transplant Immunosuppressant Drugs 1.2 Organ Transplant Immunosuppressant Drugs Segment by Type 1.2.1 Global Organ Transplant Immunosuppressant Drugs Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Antibodies 1.2.3 Antiproliferative Agents 1.2.4 Calcineurin Inhibitors 1.2.5 mTOR Inhibitors 1.2.6 Steroids 1.3 Organ Transplant Immunosuppressant Drugs Segment by Application 1.3.1 Organ Transplant Immunosuppressant Drugs Sales Comparison by Application: (2021-2027) 1.3.2 Bone Marrow Transplant 1.3.3 Heart Transplant 1.3.4 Kidney Transplant 1.3.5 Liver Transplant 1.3.6 Lung Transplant 1.4 Global Organ Transplant Immunosuppressant Drugs Market Size Estimates and Forecasts 1.4.1 Global Organ Transplant Immunosuppressant Drugs Revenue 2016-2027 1.4.2 Global Organ Transplant Immunosuppressant Drugs Sales 2016-2027 1.4.3 Organ Transplant Immunosuppressant Drugs Market Size by Region: 2016 Versus 2021 Versus 2027 2 Organ Transplant Immunosuppressant Drugs Market Competition by Manufacturers 2.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Manufacturers (2016-2021) 2.2 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Organ Transplant Immunosuppressant Drugs Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Organ Transplant Immunosuppressant Drugs Manufacturing Sites, Area Served, Product Type 2.5 Organ Transplant Immunosuppressant Drugs Market Competitive Situation and Trends 2.5.1 Organ Transplant Immunosuppressant Drugs Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Organ Transplant Immunosuppressant Drugs Players Market Share by Revenue 2.5.3 Global Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Organ Transplant Immunosuppressant Drugs Retrospective Market Scenario by Region 3.1 Global Organ Transplant Immunosuppressant Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Organ Transplant Immunosuppressant Drugs Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country 3.3.1 North America Organ Transplant Immunosuppressant Drugs Sales by Country 3.3.2 North America Organ Transplant Immunosuppressant Drugs Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country 3.4.1 Europe Organ Transplant Immunosuppressant Drugs Sales by Country 3.4.2 Europe Organ Transplant Immunosuppressant Drugs Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region 3.5.2 Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country 3.6.1 Latin America Organ Transplant Immunosuppressant Drugs Sales by Country 3.6.2 Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Organ Transplant Immunosuppressant Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country 3.7.2 Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Organ Transplant Immunosuppressant Drugs Historic Market Analysis by Type 4.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2016-2021) 4.2 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Type (2016-2021) 4.3 Global Organ Transplant Immunosuppressant Drugs Price by Type (2016-2021) 5 Global Organ Transplant Immunosuppressant Drugs Historic Market Analysis by Application 5.1 Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2016-2021) 5.2 Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Application (2016-2021) 5.3 Global Organ Transplant Immunosuppressant Drugs Price by Application (2016-2021) 6 Key Companies Profiled 6.1 F. Hoffmann-La Roche Ltd. 6.1.1 F. Hoffmann-La Roche Ltd. Corporation Information 6.1.2 F. Hoffmann-La Roche Ltd. Description and Business Overview 6.1.3 F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.1.4 F. Hoffmann-La Roche Ltd. Product Portfolio 6.1.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates 6.2 Sanofi 6.2.1 Sanofi Corporation Information 6.2.2 Sanofi Description and Business Overview 6.2.3 Sanofi Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Sanofi Product Portfolio 6.2.5 Sanofi Recent Developments/Updates 6.3 AbbVie, Inc. 6.3.1 AbbVie, Inc. Corporation Information 6.3.2 AbbVie, Inc. Description and Business Overview 6.3.3 AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.3.4 AbbVie, Inc. Product Portfolio 6.3.5 AbbVie, Inc. Recent Developments/Updates 6.4 Allergan plc. 6.4.1 Allergan plc. Corporation Information 6.4.2 Allergan plc. Description and Business Overview 6.4.3 Allergan plc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Allergan plc. Product Portfolio 6.4.5 Allergan plc. Recent Developments/Updates 6.5 Astellas Pharma, Inc. 6.5.1 Astellas Pharma, Inc. Corporation Information 6.5.2 Astellas Pharma, Inc. Description and Business Overview 6.5.3 Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Astellas Pharma, Inc. Product Portfolio 6.5.5 Astellas Pharma, Inc. Recent Developments/Updates 6.6 Bristol-Myers Squibb Company 6.6.1 Bristol-Myers Squibb Company Corporation Information 6.6.2 Bristol-Myers Squibb Company Description and Business Overview 6.6.3 Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Bristol-Myers Squibb Company Product Portfolio 6.6.5 Bristol-Myers Squibb Company Recent Developments/Updates 6.7 Hoffmann-La Roche Ltd. 6.6.1 Hoffmann-La Roche Ltd. Corporation Information 6.6.2 Hoffmann-La Roche Ltd. Description and Business Overview 6.6.3 Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Hoffmann-La Roche Ltd. Product Portfolio 6.7.5 Hoffmann-La Roche Ltd. Recent Developments/Updates 6.8 GlaxoSmithKline plc 6.8.1 GlaxoSmithKline plc Corporation Information 6.8.2 GlaxoSmithKline plc Description and Business Overview 6.8.3 GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.8.4 GlaxoSmithKline plc Product Portfolio 6.8.5 GlaxoSmithKline plc Recent Developments/Updates 6.9 Janssen Pharmaceutical 6.9.1 Janssen Pharmaceutical Corporation Information 6.9.2 Janssen Pharmaceutical Description and Business Overview 6.9.3 Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Janssen Pharmaceutical Product Portfolio 6.9.5 Janssen Pharmaceutical Recent Developments/Updates 6.10 Novartis AG 6.10.1 Novartis AG Corporation Information 6.10.2 Novartis AG Description and Business Overview 6.10.3 Novartis AG Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Novartis AG Product Portfolio 6.10.5 Novartis AG Recent Developments/Updates 6.11 Pfizer, Inc. 6.11.1 Pfizer, Inc. Corporation Information 6.11.2 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Description and Business Overview 6.11.3 Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Pfizer, Inc. Product Portfolio 6.11.5 Pfizer, Inc. Recent Developments/Updates 6.12 Veloxis Pharmaceuticals 6.12.1 Veloxis Pharmaceuticals Corporation Information 6.12.2 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Description and Business Overview 6.12.3 Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Veloxis Pharmaceuticals Product Portfolio 6.12.5 Veloxis Pharmaceuticals Recent Developments/Updates 7 Organ Transplant Immunosuppressant Drugs Manufacturing Cost Analysis 7.1 Organ Transplant Immunosuppressant Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Organ Transplant Immunosuppressant Drugs 7.4 Organ Transplant Immunosuppressant Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Organ Transplant Immunosuppressant Drugs Distributors List 8.3 Organ Transplant Immunosuppressant Drugs Customers 9 Organ Transplant Immunosuppressant Drugs Market Dynamics 9.1 Organ Transplant Immunosuppressant Drugs Industry Trends 9.2 Organ Transplant Immunosuppressant Drugs Growth Drivers 9.3 Organ Transplant Immunosuppressant Drugs Market Challenges 9.4 Organ Transplant Immunosuppressant Drugs Market Restraints 10 Global Market Forecast 10.1 Organ Transplant Immunosuppressant Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Organ Transplant Immunosuppressant Drugs by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Organ Transplant Immunosuppressant Drugs by Type (2022-2027) 10.2 Organ Transplant Immunosuppressant Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Organ Transplant Immunosuppressant Drugs by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Organ Transplant Immunosuppressant Drugs by Application (2022-2027) 10.3 Organ Transplant Immunosuppressant Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Organ Transplant Immunosuppressant Drugs by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Organ Transplant Immunosuppressant Drugs by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) Growth Rate Comparison by Type (2021-2027) Table 2. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) Comparison by Application (2021-2027) Table 3. Global Organ Transplant Immunosuppressant Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Organ Transplant Immunosuppressant Drugs Covered in This Study Table 5. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) of Key Manufacturers (2016-2021) Table 6. Global Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers (2016-2021) Table 7. Global Organ Transplant Immunosuppressant Drugs Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Organ Transplant Immunosuppressant Drugs Average Price (USD/ Dose) of Key Manufacturers (2016-2021) Table 10. Manufacturers Organ Transplant Immunosuppressant Drugs Manufacturing Sites and Area Served Table 11. Manufacturers Organ Transplant Immunosuppressant Drugs Product Type Table 12. Global Organ Transplant Immunosuppressant Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Organ Transplant Immunosuppressant Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Organ Transplant Immunosuppressant Drugs as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Organ Transplant Immunosuppressant Drugs Sales by Region (2016-2021) & (K Doses) Table 16. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2016-2021) Table 17. Global Organ Transplant Immunosuppressant Drugs Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021) & (K Doses) Table 19. North America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2021) Table 20. North America Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2021) Table 22. Europe Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021) & (K Doses) Table 23. Europe Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2021) Table 24. Europe Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales by Region (2016-2021) & (K Doses) Table 27. Asia Pacific Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2016-2021) Table 30. Latin America Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021) & (K Doses) Table 31. Latin America Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2021) Table 32. Latin America Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales by Country (2016-2021) & (K Doses) Table 35. Middle East and Africa Organ Transplant Immunosuppressant Drugs Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Organ Transplant Immunosuppressant Drugs Revenue Market Share by Country (2016-2021) Table 38. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Type (2016-2021) Table 39. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Type (2016-2021) Table 40. Global Organ Transplant Immunosuppressant Drugs Revenue (Million US$) by Type (2016-2021) Table 41. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Type (2016-2021) Table 42. Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Type (2016-2021) Table 43. Global Organ Transplant Immunosuppressant Drugs Sales (K Doses) by Application (2016-2021) Table 44. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Application (2016-2021) Table 45. Global Organ Transplant Immunosuppressant Drugs Revenue (Million US$) by Application (2016-2021) Table 46. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Application (2016-2021) Table 47. Global Organ Transplant Immunosuppressant Drugs Price (USD/ Dose) by Application (2016-2021) Table 48. F. Hoffmann-La Roche Ltd. Corporation Information Table 49. F. Hoffmann-La Roche Ltd. Description and Business Overview Table 50. F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 51. F. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Product Table 52. F. Hoffmann-La Roche Ltd. Recent Developments/Updates Table 53. Sanofi Corporation Information Table 54. Sanofi Description and Business Overview Table 55. Sanofi Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 56. Sanofi Organ Transplant Immunosuppressant Drugs Product Table 57. Sanofi Recent Developments/Updates Table 58. AbbVie, Inc. Corporation Information Table 59. AbbVie, Inc. Description and Business Overview Table 60. AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 61. AbbVie, Inc. Organ Transplant Immunosuppressant Drugs Product Table 62. AbbVie, Inc. Recent Developments/Updates Table 63. Allergan plc. Corporation Information Table 64. Allergan plc. Description and Business Overview Table 65. Allergan plc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 66. Allergan plc. Organ Transplant Immunosuppressant Drugs Product Table 67. Allergan plc. Recent Developments/Updates Table 68. Astellas Pharma, Inc. Corporation Information Table 69. Astellas Pharma, Inc. Description and Business Overview Table 70. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 71. Astellas Pharma, Inc. Organ Transplant Immunosuppressant Drugs Product Table 72. Astellas Pharma, Inc. Recent Developments/Updates Table 73. Bristol-Myers Squibb Company Corporation Information Table 74. Bristol-Myers Squibb Company Description and Business Overview Table 75. Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 76. Bristol-Myers Squibb Company Organ Transplant Immunosuppressant Drugs Product Table 77. Bristol-Myers Squibb Company Recent Developments/Updates Table 78. Hoffmann-La Roche Ltd. Corporation Information Table 79. Hoffmann-La Roche Ltd. Description and Business Overview Table 80. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 81. Hoffmann-La Roche Ltd. Organ Transplant Immunosuppressant Drugs Product Table 82. Hoffmann-La Roche Ltd. Recent Developments/Updates Table 83. GlaxoSmithKline plc Corporation Information Table 84. GlaxoSmithKline plc Description and Business Overview Table 85. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 86. GlaxoSmithKline plc Organ Transplant Immunosuppressant Drugs Product Table 87. GlaxoSmithKline plc Recent Developments/Updates Table 88. Janssen Pharmaceutical Corporation Information Table 89. Janssen Pharmaceutical Description and Business Overview Table 90. Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 91. Janssen Pharmaceutical Organ Transplant Immunosuppressant Drugs Product Table 92. Janssen Pharmaceutical Recent Developments/Updates Table 93. Novartis AG Corporation Information Table 94. Novartis AG Description and Business Overview Table 95. Novartis AG Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 96. Novartis AG Organ Transplant Immunosuppressant Drugs Product Table 97. Novartis AG Recent Developments/Updates Table 98. Pfizer, Inc. Corporation Information Table 99. Pfizer, Inc. Description and Business Overview Table 100. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 101. Pfizer, Inc. Organ Transplant Immunosuppressant Drugs Product Table 102. Pfizer, Inc. Recent Developments/Updates Table 103. Veloxis Pharmaceuticals Corporation Information Table 104. Veloxis Pharmaceuticals Description and Business Overview Table 105. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Sales (K Doses), Revenue (Million US$), Price (USD/ Dose) and Gross Margin (2016-2021) Table 106. Veloxis Pharmaceuticals Organ Transplant Immunosuppressant Drugs Product Table 107. Veloxis Pharmaceuticals Recent Developments/Updates Table 108. Production Base and Market Concentration Rate of Raw Material Table 109. Key Suppliers of Raw Materials Table 110. Organ Transplant Immunosuppressant Drugs Distributors List Table 111. Organ Transplant Immunosuppressant Drugs Customers List Table 112. Organ Transplant Immunosuppressant Drugs Market Trends Table 113. Organ Transplant Immunosuppressant Drugs Growth Drivers Table 114. Organ Transplant Immunosuppressant Drugs Market Restraints Table 115. Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Type (2022-2027) & (K Doses) Table 116. Global Organ Transplant Immunosuppressant Drugs Sales Market Share Forecast by Type (2022-2027) Table 117. Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Type (2022-2027) & (US$ Million) Table 118. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share Forecast by Type (2022-2027) Table 119. Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Application (2022-2027) & (K Doses) Table 120. Global Organ Transplant Immunosuppressant Drugs Sales Market Share Forecast by Application (2022-2027) Table 121. Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Application (2022-2027) & (US$ Million) Table 122. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share Forecast by Application (2022-2027) Table 123. Global Organ Transplant Immunosuppressant Drugs Sales Forecast by Region (2022-2027) & (K Doses) Table 124. Global Organ Transplant Immunosuppressant Drugs Sales Market Share Forecast by Region (2022-2027) Table 125. Global Organ Transplant Immunosuppressant Drugs Revenue Forecast by Region (2022-2027) & (US$ Million) Table 126. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share Forecast by Region (2022-2027) Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Organ Transplant Immunosuppressant Drugs Figure 2. Global Organ Transplant Immunosuppressant Drugs Market Share by Type in 2020 & 2027 Figure 3. Antibodies Product Picture Figure 4. Antiproliferative Agents Product Picture Figure 5. Calcineurin Inhibitors Product Picture Figure 6. mTOR Inhibitors Product Picture Figure 7. Steroids Product Picture Figure 8. Global Organ Transplant Immunosuppressant Drugs Market Share by Application in 2020 & 2027 Figure 9. Bone Marrow Transplant Figure 10. Heart Transplant Figure 11. Kidney Transplant Figure 12. Liver Transplant Figure 13. Lung Transplant Figure 14. Global Organ Transplant Immunosuppressant Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 15. Global Organ Transplant Immunosuppressant Drugs Market Size 2016-2027 (US$ Million) Figure 16. Global Organ Transplant Immunosuppressant Drugs Sales 2016-2027 (K Doses) Figure 17. Global Organ Transplant Immunosuppressant Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 18. Organ Transplant Immunosuppressant Drugs Sales Share by Manufacturers in 2020 Figure 19. Global Organ Transplant Immunosuppressant Drugs Revenue Share by Manufacturers in 2020 Figure 20. The Global 5 and 10 Largest Organ Transplant Immunosuppressant Drugs Players: Market Share by Revenue in 2020 Figure 21. Organ Transplant Immunosuppressant Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 22. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region (2016-2021) Figure 23. Global Organ Transplant Immunosuppressant Drugs Sales Market Share by Region in 2020 Figure 24. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region (2016-2021) Figure 25. Global Organ Transplant Immunosuppressant Drugs Revenue Market Share by Region in 2020 Figure 26. U.S. Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Canada Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. Germany Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. France Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. U.K. Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Italy Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Russia Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. China Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Japan Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. South Korea Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. India Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Australia Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Taiwan Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Indonesia Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Thailand Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Malaysia Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Philippines Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Vietnam Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Mexico Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Brazil Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Argentina Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Turkey Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. Saudi Arabia Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. U.A.E Organ Transplant Immunosuppressant Drugs Revenue Growth Rate (2016-2021) (US$ Million) Figure 50. Sales Market Share of Organ Transplant Immunosuppressant Drugs by Type (2016-2021) Figure 51. Sales Market Share of Organ Transplant Immunosuppressant Drugs by Application (2016-2021) Figure 52. Sales Market Share of Organ Transplant Immunosuppressant Drugs by Application in 2020 Figure 53. Revenue Share of Organ Transplant Immunosuppressant Drugs by Application (2016-2021) Figure 54. Revenue Share of Organ Transplant Immunosuppressant Drugs by Application in 2020 Figure 55. Manufacturing Cost Structure of Organ Transplant Immunosuppressant Drugs Figure 56. Manufacturing Process Analysis of Organ Transplant Immunosuppressant Drugs Figure 57. Organ Transplant Immunosuppressant Drugs Industrial Chain Analysis Figure 58. Channels of Distribution Figure 59. Distributors Profiles Figure 60. Bottom-up and Top-down Approaches for This Report Figure 61. Data Triangulation Figure 62. Key Executives Interviewed

F. Hoffmann-La Roche Ltd. Sanofi AbbVie, Inc. Allergan plc. Astellas Pharma, Inc. Bristol-Myers Squibb Company Hoffmann-La Roche Ltd. GlaxoSmithKline plc Janssen Pharmaceutical Novartis AG Pfizer, Inc. Veloxis Pharmaceuticals